Brief: Corline Biomedical: Canada To Grant Kardium Up To C$31.25 Mln For Manufacturing Capacity Expansion
BRIEF-Corline Biomedical: Canada To Grant Kardium Up To C$31.25 Mln For Manufacturing Capacity Expansion Aug 28 (Reuters) - Corline Biomedical AB CLBIO.ST:
SAID ON THURSDAY CORLINE PARTNER KARDIUM SECURES UP TO C$31.25 MILLION IN INVESTMENT SUPPORT FROM CANADIAN GOVERNMENT
TO INVEST C$125 MILLION TO EXPAND MANUFACTURING CAPACITY FOR GLOBE PULSED FIELD SYSTEM IN CANADA
INVESTMENT TO FINANCE EXPANSION OF CLEANROOM CAPACITY TO 30,000 UNITS PER YEAR
PROJECT TO CREATE AND RETAIN A TOTAL OF 1,000 SKILLED JOBS IN BRITISH COLUMBIA
Source text for Workspace: CLBIO.ST
Further company coverage: nGNE7XnDCC
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Corline Biomedical AB
See all newsBrief: Corline Biomedical Expectes Positive EBITDA In 2027
Brief: Corline Biomedical: Canada To Grant Kardium Up To C$31.25 Mln For Manufacturing Capacity Expansion
Brief: Corline Biomedical Q2 Net Sales Amount To SEK 4.7 Million
Brief: Corline Biomedical Partner Kardium Receives Approval For Globe Pulsed Field System In Canada
Brief: Corline Biomedical Q1 Result After Financial Items At SEK -2.5 Mln